Zhejiang Starry Pharm Co Ltd (603520) — Cash Flow Quality Index
Zhejiang Starry Pharm Co Ltd (603520) has a Cash Flow Quality Index of 3.54x as of June 2025. Operating cash flow of CN¥52.35 Million exceeds net income of CN¥14.79 Million, indicating high earnings quality where cash backs reported profits. Explore Zhejiang Starry Pharm Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Starry Pharm Co Ltd Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Zhejiang Starry Pharm Co Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 603520 operating cash flow.
Annual Cash Flow Quality Index for Zhejiang Starry Pharm Co Ltd (2011–2025)
Year-by-year earnings quality comparison for Zhejiang Starry Pharm Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | CN¥3.67 Million | CN¥10.23 Million | ▼ -65.6% |
| 2023 | 1.04x | CN¥46.13 Million | CN¥44.23 Million | ▼ -32.4% |
| 2021 | 1.54x | CN¥508.84 Million | CN¥329.77 Million | ▲ +124.3% |
| 2020 | 0.69x | CN¥174.48 Million | CN¥253.60 Million | ▼ -49.0% |
| 2019 | 1.35x | CN¥246.77 Million | CN¥182.92 Million | ▼ -32.8% |
| 2018 | 2.01x | CN¥191.84 Million | CN¥95.54 Million | ▲ +803.1% |
| 2017 | 0.22x | CN¥18.10 Million | CN¥81.42 Million | ▲ +119.8% |
| 2016 | 0.10x | CN¥7.68 Million | CN¥75.91 Million | ▼ -92.2% |
| 2015 | 1.29x | CN¥94.88 Million | CN¥73.47 Million | ▼ -39.9% |
| 2014 | 2.15x | CN¥144.00 Million | CN¥67.03 Million | ▲ +79.9% |
| 2013 | 1.19x | CN¥74.99 Million | CN¥62.80 Million | ▼ -59.6% |
| 2012 | 2.95x | CN¥103.34 Million | CN¥35.00 Million | ▲ +584.0% |
| 2011 | -0.61x | CN¥-41.07 Million | CN¥67.33 Million | — |